Anti-h CD22-ScFv-4-1BB-CD3ζ (GFP-Puro)

$790.00

SKU: LVP1661 Category:

Description

Pre-made Lentivirus express the CAR construct of “3xFLAG-anti-CD22-ScFV (VL-VH)-CD8 hinge-4-1BB-CD3ζ”. It contains the GFP-Puromycin dual marker, allowing the selection of the transduced cells via antibiotic killing, or via GFP positive cell sorting.

This construct, contains the N-term 3xFLAG taggedCD22-scFv [VH-(G4S)x4-VL]” recognition domain, linked to 4-1BB stimulatory domain, expressed under the enhance EF1a promoter. The lentivector’s core structure is represented by the scheme below. 

CAR Lentivector Scheme

CD22 is a cell surface glycoprotein expressed on B cells. It is involved in B cell activation and regulation. CD22 is a target in CAR-T therapy for B-cell malignancies, especially in cases where CD19-targeted CAR-T cells may face challenges. CD22 CAR-T cells offer an alternative approach in certain B-cell lymphomas and leukemias. This CAR construct assembled the identified anti-human CD22 monoclonal antibodies’ coding sequence (clone m971, 704Y). (see Reference1Reference2).

see details in Product Manual.

4-1BB (CD137) is a surface glycoprotein present on activated T Lymphocytes, CD4+ and CD8+ T cells. It binds to its ligand expressed on antigen-presenting cells (macrophages and activated B cells). It promotes T-cell antitumor activity. 4-1BB is one of the most widely studied co-stimulatory domain used in CAR design.

CD3ζ (T-cell receptor zeta) is expressed by T cells and NK cells. It together with T-cell receptor and CD3γ, δ, ε chain, forms the TCR-CD3 complex. CD3-zeta is the most commonly used activation component of CARs. It transmits an activation signal to the T cell after the antigen is bound. It can be coupled with additional co-stimulatory signaling for the complete activation.

Negative Controls:  To validate the specificity of the targeted CAR-T killing, you can use the negative control CAR lentivirus: the CAR-ctr7 that has the same lentivector backbone but removed the recognition domain.

Amount: 200 ul/vial at titer of 1×108 IFU/ml, concentrated lentivirus provided in PBS solution, premixed with 10x polybrene (60ug/ml), premade, ready to ship in dry-ice package.

CAT#: LVP1661